Orange Book product · Generic (ANDA)
ROPIVACAINE HYDROCHLORIDE
ROPIVACAINE HYDROCHLORIDE
At a glance
Jul 13, 2016
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 13, 2016
10 yr 1 mo ago
Today
Pharmaceutical detail
Active ingredient
ROPIVACAINE HYDROCHLORIDE
Strength
40MG/20ML (2MG/ML)
Dosage form
SOLUTION
Route
INJECTION
TE code
AP
Application
ANDA 205612
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ROPIVACAINE HYDROCHLORIDE
- 2011NAROPINBrand (NDA)
NDA 020533 · FRESENIUS KABI USA
- 2025ROPIVACAINE HYDROCHLORIDEGeneric (ANDA)
ANDA 219883 · ANTHEA PHARMA
- 2024ROPIVACAINE HYDROCHLORIDEGeneric (ANDA)
ANDA 211907 · HIKMA
- 2024ROPIVACAINE HYDROCHLORIDEGeneric (ANDA)
ANDA 218713 · KINDOS
- 2023ROPIVACAINE HYDROCHLORIDEGeneric (ANDA)
ANDA 206091 · MYLAN LABS LTD
- 2023ROPIVACAINE HYDROCHLORIDEGeneric (ANDA)
ANDA 216605 · AMNEAL
- 2022ROPIVACAINE HYDROCHLORIDEGeneric (ANDA)
ANDA 210102 · GLAND
- 2020ROPIVACAINE HYDROCHLORIDEGeneric (ANDA)
ANDA 214074 · HIKMA
- 2020ROPIVACAINE HYDROCHLORIDEGeneric (ANDA)
ANDA 212808 · CAPLIN
- 2018ROPIVACAINE HYDROCHLORIDEGeneric (ANDA)
ANDA 207636 · SOMERSET THERAPS LLC
- 2018ROPIVACAINE HYDROCHLORIDEGeneric (ANDA)
ANDA 206166 · INFORLIFE
- 2018ROPIVACAINE HYDROCHLORIDEGeneric (ANDA)
ANDA 204636 · RISING
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
